Sign in
ALEC Stock Price, Chart, Stats & News
Alector, Inc.
Save
Alector, Inc. (ALEC) does not currently pay a dividend.
168.20M
Market cap
–
Current P/E
8.47x
Forward P/E
ALEC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 89.27% |
Operating margin | -692.83% |
Pretax margin | -678.36% |
Net margin | -679.16% |
Effective tax rate | -0.12% |
ROA | -48.74% |
ROE | -224.96% |
D/E | 1.18x |
Interest coverage ratio | – |
ALEC valuation
P/E | – |
P/S | 10.49x |
P/B | 6.72x |
P/CF | -1.12x |
P/FCF | -1.20x |
P/OCF | -1.12x |
PEG | 0.05x |
EV multiple | -1.83x |
About
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders.
Similar securities
Based on sector and market capitalization
Report issue